Q2 Clinic, the first international chain of Endocannabinology clinics, today announced the appointment of Dr. Peter Grinspoon, M.D. as Chief Medical Director (CMD).
Dr. Grinspoon is a primary care physician and cannabis specialist at Massachusetts General Hospital and an Instructor in Medicine at Harvard Medical School. He is a certified Health and Wellness Coach as well as a board member of the advocacy group Doctors for Cannabis Regulation.
With more than two decades of experience, Dr. Grinspoon will lead Q2 Clinic’s international network of doctors giving his advice on medical matters, developing clinical protocols and quality assurance and bringing his expertise on the field of Endocannabinology to ensure that the company provides the best possible care to patients.
Read the full article at EINNews.com